Letter from Paul Reider

Letter from Paul Reider

Country Manager, Canada for Ipsen Biopharmaceuticals

Welcome to the Ipsen Biopharmaceuticals Canada website.

At Ipsen Biopharmaceuticals, our mission is to provide hope for the patients whose lives are challenged by difficult-to-treat diseases. Our external innovation, development and commercialization approach represents the best of how we regard science – working in close partnership with like-minded partners who have promising assets aligned with our core therapeutic areas: oncology, neurosciences and rare diseases.

Ipsen’s decision to launch in Canada in January, 2015 was based on the world-class research and clinical development taking place at leading institutions in Canada and in particular, in the Greater Toronto area. Today, Ipsen has developed strong partnerships, including membership with Innovative Medicines Canada to drive the development and delivery of key therapies to patients in need. Moving forward, we will continue to strengthen relationships with healthcare providers, researchers and organizations across the Canadian healthcare ecosystem

In just two and a half years, Ipsen Biopharmaceuticals Canada has grown to a team of 50 and delivered important treatments to patients with high unmet need across the country. As the new Country Manager, I look forward to continuing to expand Ipsen’s footprint in Canada and to maintaining our unwavering commitment to our patients and customers. I am honored to join the Ipsen team in Canada and lead the next phase of our growth in this critical market.